Personalis PSNL 深 沪
等待开盘 08-18 09:30:00 美东时间
13.99
-0.050
-0.36%
华盛通- 最 高14.23
- 今 开13.90
- 成交量 44.53万股
- 最 低 13.90
- 昨 收 14.04
- 总市值 14.94亿
- 52周最高 16.39
- 市盈率 静 --
- 换手率 0.42%
- 52周最低 4.6524
- 委 比 -50.90%
- 总股本 1.07亿
- 历史最高 53.46
- 量 比 0.28
- 振 幅 2.35%
- 历史最低 0.8906
- 每 手 1
- 风险率 2.61%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多AI医疗龙头宣称首次盈利，我们翻完财报：赚钱的并不是AI
来源：虎嗅网 在一片火热的当下，AI医疗真的赚钱了吗？ 近期，美股AI医疗龙头Tempus AI（NASDAQ：TEM）发布2026年Q2最新财报...
08-14 10:28
朝阳门并购堂 | 2026年7月并购重组市场观察
（来源：中信建投证券投行委） 一、新增重组事件 （一）精测电子（300567.SZ）停牌筹划重组 （二）新芝生物（920685.BJ）停牌筹划重组 ...
08-13 16:52
Biomea Fusion Announces First Patient Dosed in OPAL Study Evaluating Icovamenib in Combination with Semaglutide in Obesity
Biomea Fusion has initiated a new arm of the OPAL study to evaluate the combination of icovamenib and low-dose semaglutide in overweight or obese individuals without type 2 diabetes. The randomized, double-blind study aims to assess the impact on weight loss, physical function, body composition, muscle health, and metabolic outcomes. The primary endpoint will be evaluated at Week 24. Preclinical data suggests icovamenib enhances semaglutide's eff...
08-13 11:00
Personalis Q2 EPS $(0.30) Misses $(0.27) Estimate, Sales $22.357M Beat $16.783M Estimate
Personalis (NASDAQ:PSNL) reported quarterly losses of $(0.30) per share which missed the analyst consensus estimate of $(0.27) by 15.38 percent. This is a 30.43 percent decrease over losses of $(0.23) per share from the same period last year. The company reported quarterly sales of $22.357 million w...
08-05 04:46
Personalis(PSNL)相关疫苗三期数据预计三季度读出 或影响估值
经济观察网 Personalis, Inc.（PSNL）为默沙东与Moderna相关疫苗提供底层检测平台，其三季度将读出相关三期中期数据，或影响自身估值及收购谈...
08-04 00:43
Are FNWD, PSNL, DSGR Obtaining Fair Deals for their Shareholders?
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. S...
07-28 07:39
美股周涨跌榜 | 超微电脑升逾24%，斩获600亿美元大单，新一季毛利率大超预期；钢铁厂商CLF劲升逾28%
超微电脑升逾24%，斩获600亿美元大单，新一季毛利率大超预期；钢铁厂商CLF劲升逾28%，Q2净亏损大幅收窄七成；HUT升逾20%，签署98亿美元算力大单>>
07-25 10:18
Merck signs licensing deals with companies including Viatris for new HIV pill
Merck (MRK) on Friday announced seven licensing agreements with generic drug manufacturers, including Viatris (VTRS), to broaden access to its experimental HIV pill, alimatravir, in low- and middle-in...
07-24 20:58
股东权益律所对Personalis收购案启动调查
多家股东权益律师事务所近日宣布，已对癌症检测公司Personalis拟被Tempus AI收购的交易展开调查，关注点集中在交易价格是否公允以及董事会是否履行...
07-22 03:43
